EZZ Life Science Holdings Limited

EZZ

AU0000130569

Pharmaceuticals

Market Closed - Australian S.E. Other stock markets 12:01:52 2024-06-03 am EDT			5-day change	1st Jan Change
1.01 ^AUD	-5.16%		+2.02%	+55.38%

May. 31	EZZ Life Science Signs Five-Year Sales Agreement with Pinehills; Shares Climb 6%	MT
May. 07	EZZ Life Science Declares Fully Franked Interim Dividend	MT

EZZ Life Science Holdings brings genomic research to the ASX

March 03, 2023 at 04:01 pm EST

(via NewsDirect)

EZZ Life Science Holdings Ltd (ASX:EZZ) Chairman Glenn Cross joins Proactive’s Elisha Newell to detail the company’s value proposition. With a focus on genomic research and gene technology, EZZ hopes to address four key human health challenges: genetic longevity, human papillomavirus, helicobacter pylori and weight management. The company has just inked a tripartite agreement with two leading multinational pharmaceutical companies, designed to bring new products and wellness solutions to the market.

Contact Details

Proactive Investors

Jonathan Jackson

+61 413 713 744

jonathan@proactiveinvestors.com

Latest news about EZZ Life Science Holdings Limited

EZZ Life Science Signs Five-Year Sales Agreement with Pinehills; Shares Climb 6%	May. 30	MT
EZZ Life Science Declares Fully Franked Interim Dividend	May. 06	MT
EZZ Life's Receipts from Customers Up 111% in Fiscal Q3	Apr. 25	MT
EZZ Life Science Completes AU$854,000 Placement with Kingstone Venture Capital	Apr. 11	MT
Renewed Rate Cut Hopes Lift Australian Shares	Mar. 27	MT
Ezz Life Science Posts 43% H1 Revenue Increase to AU$21.7 Million, EBITDA Falls 7% to AU$1.7 Million	Mar. 26	MT
EZZ Life Science Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 28	CI
EZZ Life Science Holdings Limited Declares Fully Franked Final Dividend for the Twelve Month Period Ended 30 June 2023, Payable on 8 December 2023	23-10-24	CI
EZZ Life Science Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-27	CI
EZZ Life Science Holdings Limited Announces Dividend of for the Six Months Ended December 31, 2022, Payable on June 23, 2023	23-05-14	CI
Ezz Life Science Declares Interim Dividend; Shares Jump 7%	23-05-14	MT
Ezz Life Science Signs Two-Year Distribution Deal	23-05-09	MT
EZZ Life Science Launches Amazon Online Store in Australia; Shares Up 8%	23-03-29	MT
30,000,000 Ordinary Shares of EZZ Life Science Holdings Limited are subject to a Lock-Up Agreement Ending on 3-MAR-2023.	23-03-02	CI
EZZ Life Science Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-26	CI
EZZ Life Science Holdings Limited Elects Qizhou Qin as Director	22-11-20	CI
EZZ Life Science Holdings Limited Declares Fully Franked Final Dividend for the Twelve Month Period Ended 30 June 2022, Payable on 16 December 2022	22-10-11	CI
EZZ Life Science Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-30	CI
Ezz Life Science Launches Overseas Flagship Store on Douyin Platform	22-05-08	MT
Ezz Life Science Holdings Limited Establishes International Store on Douyin	22-05-08	CI
EZZ Life Science Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-27	CI
EZZ Life Science Holdings Appoints Glenn Cross as Chairperson and Non-Executive Director	21-11-30	CI
EZZ Life Science Holdings Limited Announces Appointments of Directors	21-11-29	CI
Ezz Life Science Chair Resigns	21-11-23	MT
EZZ Life Science Holdings Limited Announces Resignation of Philippa Lewis as Chair and Non-Executive Director	21-11-22	CI

Chart EZZ Life Science Holdings Limited

Duration

Period

More charts

Company Profile

EZZ Life Science Holdings Limited is an Australia-based genomic life science company. The Company is engaged in research and development in genomics and precision nutrition with a focus on four human health challenges, including genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. It formulates, produces, markets and distributes health supplements under the brand of EZZ to retailers and consumers domestically and internationally. The Company is also a wholesale distributor of skin care products under the EAORON brand in Australia and New Zealand to pharmacies, supermarkets and specialist retailers. Its products under the EZZ brand include EZZ Hair Growth Spray, EZZ Hair Scrub, EZZ Hair Mask, EZZ Anti-frizz Hair Spray, EZZ Biotic Engastro Capsule, EZZ Coffee Jelly and EZZ Iron Jelly. The EZZ products cover market segments, including vitamin and dietary supplements, sports nutrition, herbal/ traditional and pediatric consumer health products.

Sector

Pharmaceuticals

Calendar

2024-08-26 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
EZZ LIFE SCIENCE HOLDINGS LIMITED	+55.38%	31.41M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+31.40%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+14.66%	240B
NOVARTIS AG	+9.25%	210B
ROCHE HOLDING AG	-5.07%	206B
AMGEN INC.	+6.17%	164B

Other Pharmaceuticals

EZZ Life Science Holdings Limited

Equities

EZZ

AU0000130569

Pharmaceuticals

EZZ Life Science Holdings brings genomic research to the ASX

Contact Details

Latest news about EZZ Life Science Holdings Limited

Chart EZZ Life Science Holdings Limited

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Other Pharmaceuticals